Lukas Bubendorf
University of Basel · 644 works · 29,740 citations · h-index 84
Top works
- Tissue microarrays for high-throughput molecular profiling of tumor specimens
- Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients
- Tissue microarrays for gene amplification surveys in many different tumor types.
- Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays.
- Hormone Therapy Failure in Human Prostate Cancer: Analysis by Complementary DNA and Tissue Microarrays
- High-Throughput Tissue Microarray Analysis to Evaluate Genes Uncovered by cDNA Microarray Screening in Renal Cell Carcinoma
- Patterns of HER-2/neu Amplification and Overexpression in Primary and Metastatic Breast Cancer
- Detecting Activation of Ribosomal Protein S6 Kinase by Complementary DNA and Tissue Microarray Analysis
- PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project
- Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade
- Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughputin situ studies
- Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression.
- 2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up
- A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee
- IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy
- Chromosomal Imbalances in Papillary Renal Cell Carcinoma
- Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers
- Ki67 LABELLING INDEX: AN INDEPENDENT PREDICTOR OF PROGRESSION IN PROSTATE CANCER TREATED BY RADICAL PROSTATECTOMY
- Prevalence and Clinical Outcomes for Patients With ALK-Positive Resected Stage I to III Adenocarcinoma: Results From the European Thoracic Oncology Platform Lungscape Project
- Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer